The tragic 9.0 earthquake and tsunamis that hit Japan a few weeks ago are having lasting consequences not only for Japan, but also for the world via radiation. One area of particular concern is the radiation that has leaked and is continuing to leak from the damaged nuclear reactors. At this point, the radiation […]
A reality check on the radiation spreading across the globe Read More »
What is Contagious cancer? Can one creature directly give another creature cancer? It appears so in dogs and that cancer is highly contagious. Contagious cancer When we think about transplants of cells, we think about hospitals and high-tech equipment used to give patients stem cells or other types of cells to help treat them for
Contagious cancer: the allograft your dog doesn’t want Read More »
CIRM announced today that it had appointed Ellen Feigal, M.D., to be its first VP for Research Development. Dr. Feigal will begin the job on Jan. 31. Dr. Feigal is a graduate of UC Davis Med School (where I am writing this from; go UC Davis SOM!) and is currently Executive Medical Director for Global
CIRM Appoints Ellen Feigal, UC Davis Grad and Executive Med Director of Amgen as VP Read More »
There is a kind of invisible cultural wall between patients such as cancer patients and biomedical scientists like me, but this wall does not have to exist and indeed it is a negative wall as patients, scientists, doctors, agencies, and advocates can achieve far more together than apart. But the wall is surprisingly strong. Last
My Cancer: how I became an advocate too Read More »
The FDA has given Advanced Cell Technology (ACT) the go ahead to begin their clinical trial using retinal progenitor cells derived from hESC by clearing the company’s IND application, bringing hope to those with vision loss and even blindness. The trial will be a combined Phase I/II to treat Stargardt’s Macular Dystrophy and has huge
One question I am frequently asked by readers and colleagues is “what other stem cell blogs or bloggers can you recommend that are written by a stem cell scientist and updated on a regular basis?” The simple but surprising answer: there are none. It’s lonely out here in cyberspace! (2020 update: The good news today
How many scientist bloggers does it take to change a light bulb? Read More »
CIRM Board Member, Jeff Sheehy, has a wonderful piece in Nature Medicine on why patient advocates play a critical role in decision making on research priorities (hat tip to Amy Adams who first blogged on Sheehy’s piece). Patient advocates bring a unique and valuable perspective to the table. Their role in guiding CIRM research funding
Why scientists must be advocates too: Jeff Sheehy Read More »
Dr. James Sherley, the scientist behind the lawsuit against federally-funded ES cell research, has penned an opinion piece in The Daily Caller today calling on NIH to, in his words, ‘do the right thing.’ However, what Sherley is really asking is for the NIH, other stem cell scientists, and all Americans to think like he
James Sherley of anti-ESC lawsuit calls on NIH to think like he does Read More »
This is the first post in a series focusing on stem cell advances related to specific diseases. Today we discuss Huntington’s Disease and a paper that came out yesterday in the journal Neuron that provides some significant insight into the mechanisms behind the disease. It is entitled: Huntingtin Is Required for Mitotic Spindle Orientation and
Huntington’s Disease, a major new finding Read More »
Update in 2020: It was kind of wild to read this post now so many years later as an “old” professor, seemingly ages from the realm of new PIs (principle investigators). What do you think? You can read more about the current state of our lab here. It’s an exciting feeling coming into a new
Advice for new PIs part I: start before you start Read More »